Roth Capital Partners advised that Applied Genetic Technologies co-development of BS01 with Bionic Sight "validates its gene therapy capabilities.".
https://www.google.com/url?rct=j&sa=t&url=https://www.streetwisereports.com/article/2021/04/07/gene-therapy-restoring-light-sensitivity-showed-impressive-dose-response-improvements.html&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNHCrhb30Q4zplTqRLwx7uyygYgtqA
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.